Browsing Tag
Chinese biotech
3 posts
Pollon Life files for Hong Kong IPO: Is Jack Ma’s stem cell bet about to pay off?
Find out how Pollon Life, backed by Jack Ma’s Yunfeng Capital, is planning a Hong Kong IPO and what it signals for China’s biotech revival.
October 29, 2025
Kelun-Biotech reports strong Phase 3 data for sacituzumab tirumotecan in HR+/HER2- breast cancer
Kelun-Biotech’s sacituzumab tirumotecan doubled PFS in HR+/HER2- breast cancer. Find out what this means for patients, investors, and China’s ADC landscape.
October 19, 2025
BioCity’s SC0062 secures second breakthrough therapy designation in China for diabetic kidney disease
BioCity Biopharma’s ETA-selective SC0062 earns second Breakthrough Therapy Designation in China for diabetic kidney disease, reinforcing its CKD potential.
June 26, 2025